These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 25865688)
1. Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation. Cui X; Li Z; Gao PJ; Gao J; Zhu JY Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):157-63. PubMed ID: 25865688 [TBL] [Abstract][Full Text] [Related]
2. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882 [TBL] [Abstract][Full Text] [Related]
4. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007 [TBL] [Abstract][Full Text] [Related]
5. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection. Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901 [TBL] [Abstract][Full Text] [Related]
6. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297 [TBL] [Abstract][Full Text] [Related]
7. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience. Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778 [TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478 [TBL] [Abstract][Full Text] [Related]
9. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672 [TBL] [Abstract][Full Text] [Related]
10. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis. Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707 [TBL] [Abstract][Full Text] [Related]
11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
12. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Xiao GQ; Yang JY; Yan LN Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006 [TBL] [Abstract][Full Text] [Related]
13. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma. Ha SY; Song DH; Hwang SH; Cho SY; Park CK Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690 [TBL] [Abstract][Full Text] [Related]
14. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation. Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696 [TBL] [Abstract][Full Text] [Related]
15. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Yao M; Yao DF; Bian YZ; Wu W; Yan XD; Yu DD; Qiu LW; Yang JL; Zhang HJ; Sai WL; Chen J Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):171-9. PubMed ID: 23558072 [TBL] [Abstract][Full Text] [Related]
16. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Roayaie S; Haim MB; Emre S; Fishbein TM; Sheiner PA; Miller CM; Schwartz ME Ann Surg Oncol; 2000 Dec; 7(10):764-70. PubMed ID: 11129425 [TBL] [Abstract][Full Text] [Related]
17. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473 [TBL] [Abstract][Full Text] [Related]
18. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy]. Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069 [TBL] [Abstract][Full Text] [Related]
19. Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma. Wang L; Pan L; Yao M; Cai Y; Dong Z; Yao D Oncotarget; 2016 Jul; 7(27):42150-42158. PubMed ID: 27286460 [TBL] [Abstract][Full Text] [Related]
20. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation. Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]